Anti-obesity agents
Semaglutide May Help Prevent Heart Attacks and Strokes in Overweight People with Heart Failure
Research suggests that a weight loss drug, semaglutide, which has been shown to reduce major adverse cardiac events such as heart attacks and strokes in obese or overweight people with cardiovascular disease, may also benefit those with heart failure. A new study found that within the group of people with